Adult Clinical Nutrition Market Size to Hit USD 34.82 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Adult Clinical Nutrition Market

5.1. COVID-19 Landscape: Adult Clinical Nutrition Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Adult Clinical Nutrition Market, By Product Type

8.1. Adult Clinical Nutrition Market Revenue and Volume, by Product Type

8.1.1. Oral Nutritional Supplements (ONS)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Enteral Nutrition

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Specialized Formulas

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Adult Clinical Nutrition Market, By Formulation Type

9.1. Adult Clinical Nutrition Market Revenue and Volume, by Formulation Type

9.1.1. Standard Formulas

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Disease-Specific Formulas

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Specialized Formulas

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Adult Clinical Nutrition Market, By Patient Type

10.1. Adult Clinical Nutrition Market Revenue and Volume, by Patient Type

10.1.1. General Adult Patients

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Geriatric Patients

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Critical Care Patients

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Oncology Patients

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Diabetic Patients

10.1.5.1. Market Revenue and Volume Forecast

10.1.5. Renal Patients

10.1.5.1. Market Revenue and Volume Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Adult Clinical Nutrition Market, By Distribution Channel

11.1. Adult Clinical Nutrition Market Revenue and Volume, by Distribution Channel

11.1.1. Hospitals and Clinics

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Retail Pharmacies

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Online Sales / E-commerce

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Home Care Settings

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Specialty Clinics / Nutrition Centers

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Adult Clinical Nutrition Market, By End User

12.1. Adult Clinical Nutrition Market Revenue and Volume, by End User

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Home Care

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Long-term Care Facilities / Nursing Homes

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Long-term Care Facilities / Nursing Homes

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Adult Clinical Nutrition Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Formulation Type

13.1.3. Market Revenue and Volume Forecast, by Patient Type

13.1.4. Market Revenue and Volume Forecast, by Distribution Channel

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Formulation Type

13.1.6.3. Market Revenue and Volume Forecast, by Patient Type

13.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6.5. Market Revenue and Volume Forecast, by End User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Formulation Type

13.1.7.3. Market Revenue and Volume Forecast, by Patient Type

13.1.7.4. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Formulation Type

13.2.3. Market Revenue and Volume Forecast, by Patient Type

13.2.4. Market Revenue and Volume Forecast, by Distribution Channel

13.2.5. Market Revenue and Volume Forecast, by End User

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Formulation Type

13.2.6.3. Market Revenue and Volume Forecast, by Patient Type

13.2.7. Market Revenue and Volume Forecast, by Distribution Channel

13.2.8. Market Revenue and Volume Forecast, by End User

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Formulation Type

13.2.9.3. Market Revenue and Volume Forecast, by Patient Type

13.2.10. Market Revenue and Volume Forecast, by Distribution Channel

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Formulation Type

13.2.12.3. Market Revenue and Volume Forecast, by Patient Type

13.2.12.4. Market Revenue and Volume Forecast, by Distribution Channel

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Formulation Type

13.2.14.3. Market Revenue and Volume Forecast, by Patient Type

13.2.14.4. Market Revenue and Volume Forecast, by Distribution Channel

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Formulation Type

13.3.3. Market Revenue and Volume Forecast, by Patient Type

13.3.4. Market Revenue and Volume Forecast, by Distribution Channel

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Formulation Type

13.3.6.3. Market Revenue and Volume Forecast, by Patient Type

13.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Formulation Type

13.3.8.3. Market Revenue and Volume Forecast, by Patient Type

13.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Formulation Type

13.3.10.3. Market Revenue and Volume Forecast, by Patient Type

13.3.10.4. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Formulation Type

13.3.11.3. Market Revenue and Volume Forecast, by Patient Type

13.3.11.4. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Formulation Type

13.4.3. Market Revenue and Volume Forecast, by Patient Type

13.4.4. Market Revenue and Volume Forecast, by Distribution Channel

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Formulation Type

13.4.6.3. Market Revenue and Volume Forecast, by Patient Type

13.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Formulation Type

13.4.8.3. Market Revenue and Volume Forecast, by Patient Type

13.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Formulation Type

13.4.10.3. Market Revenue and Volume Forecast, by Patient Type

13.4.10.4. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Formulation Type

13.4.11.3. Market Revenue and Volume Forecast, by Patient Type

13.4.11.4. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Formulation Type

13.5.3. Market Revenue and Volume Forecast, by Patient Type

13.5.4. Market Revenue and Volume Forecast, by Distribution Channel

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Formulation Type

13.5.6.3. Market Revenue and Volume Forecast, by Patient Type

13.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Formulation Type

13.5.8.3. Market Revenue and Volume Forecast, by Patient Type

13.5.8.4. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Nestlé Health Science

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Danone S.A.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Fresenius Kabi AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Baxter International Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Mead Johnson Nutrition

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Koninklijke DSM N.V.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. B. Braun Melsungen AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Perrigo Company plc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Aenova Group

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The adult clinical nutrition market size is expected to increase from USD 21.56 billion in 2024 to USD 34.82 billion by 2034.

The adult clinical nutrition market is expected to grow at a compound annual growth rate (CAGR) of around 4.91% from 2025 to 2034.

The major players in the adult clinical nutrition market include Abbott Laboratories, Nestlé Health Science, Danone S.A., Fresenius Kabi AG, Baxter International Inc., Mead Johnson Nutrition, Koninklijke DSM N.V., B. Braun Melsungen AG, Perrigo Company plc, Aenova Group, Nutricia (Danone subsidiary), Kate Farms Inc., Clinimed Ltd, Otsuka Pharmaceutical Co., Ltd., Vitaflo International Ltd, Trophic Medical, Eastman Kodak Company, Medtrition Inc., BioCare Copenhagen A/S, Nestlé Nutrition Institute, and Amway.

The driving factors of the adult clinical nutrition market are the aging population, the rising prevalence of chronic diseases, and greater awareness of specialized nutritional needs.

North America region will lead the global adult clinical nutrition market during the forecast period 2025 to 2034.